1066.HK - Shandong Weigao Group Medical Polymer Company Limited

HKSE - HKSE Delayed Price. Currency in HKD
6.280
+0.090 (+1.45%)
At close: 4:08PM HKT
Stock chart is not supported by your current browser
Previous Close6.190
Open6.310
Bid6.280 x 0
Ask6.290 x 0
Day's Range6.200 - 6.360
52 Week Range4.770 - 7.000
Volume11,100,000
Avg. Volume12,042,821
Market Cap28.4B
Beta0.46
PE Ratio (TTM)13.43
EPS (TTM)0.468
Earnings DateAug 21, 2018 - Aug 27, 2018
Forward Dividend & Yield0.11 (1.95%)
Ex-Dividend Date2018-06-21
1y Target Est5.82
  • Reuterslast month

    BRIEF-Shandong Weigao Group Medical Polymer Co gets Approval For Participation In H Share Full Circulation Pilot Project

    July 10 (Reuters) - Shandong Weigao Group Medical Polymer Co Ltd: * RECEIVED APPROVAL LETTER FROM CSRC IN RESPECT OF PARTICIPATION IN THE H SHARE FULL CIRCULATION PILOT PROJECT * CO IS ALLOWED TO CONVERT ...

  • Top 3 Undervalued Stocks For The Month
    Simply Wall St.4 months ago

    Top 3 Undervalued Stocks For The Month

    Companies with shares trading at a market price below what they are actually worth, such as Yuexiu Transport Infrastructure and 361 Degrees International, are deemed undervalued. Smart investors can makeRead More...

  • Reuters5 months ago

    BRIEF-Shandong Weigao Group Medical Polymer Posts FY Net Profit Attributable Of RMB1.34 Bln

    March 27 (Reuters) - Shandong Weigao Group Medical Polymer Co Ltd: * RECOMMENDED PAYMENT OF A FINAL DIVIDEND OF RMB0.046 PER SHARE * ‍FY NET PROFIT ATTRIBUTABLE RMB1.34 BILLION, UP 2.3 PERCENT​ * FY TURNOVER ...

  • Best-In-Class Undervalued Stocks
    Simply Wall St.6 months ago

    Best-In-Class Undervalued Stocks

    Companies with shares trading at a market price below what they are actually worth, such as Hua Hong Semiconductor and Shandong Weigao Group Medical Polymer, are deemed undervalued. Investors canRead More...

  • Shandong Weigao Group Medical Polymer Co. Ltd. : Overvalued relative to peers, but may deserve another look
    Capital Cube8 months ago

    Shandong Weigao Group Medical Polymer Co. Ltd. : Overvalued relative to peers, but may deserve another look

    Categories: Yahoo FinanceShandong Weigao Group Medical Polymer Co. Ltd. relative valuation is now OVERVALUED. It was previously rated NEUTRAL, and has a fundamental analysis score of 47. Our analysis is based on comparing Shandong Weigao Group Medical Polymer Co. Ltd. with the following peers – LifeTech Scientific Corporation, PW Medtech Group Ltd., Nanjing Sinolife United Co., Ltd. ... Read more (Read more...)

  • Reuters9 months ago

    BRIEF-Shandong Weigao Group Medical Polymer says Nikkiso Agreed To Subscribe For Additional Capital In Unit ​

    Dec 4 (Reuters) - Shandong Weigao Group Medical Polymer Co Ltd: * SHANDONG WEIGAO GROUP MEDICAL POLYMER CO - ‍XIA LIE BO HAS RESIGNED AS AN EXECUTIVE DIRECTOR WITH EFFECT FROM 4 DEC 2017​ * ‍ NIKKISO AGREED ...

  • Shandong Weigao to Buy Argon in China's Latest U.S. Health Deal
    Bloomberg11 months ago

    Shandong Weigao to Buy Argon in China's Latest U.S. Health Deal

    Shandong Weigao Group Medical Polymer Co. agreed to buy closely held Argon Medical Devices Inc. for $850 million, continuing a string of deals by Chinese companies seeking to gain a foothold in the U.S. ...

  • Reuters11 months ago

    Chinese medical devices maker to buy US-based Argon for $850 mln

    China's Shandong Weigao Group Medical Polymer Co Ltd has agreed to acquire US-based and unlisted Argon Medical Devices Holdings Inc for $850 million, as part of its overseas expansion drive. Weigao Group, mainly engaged in the production and sale of medical devices, orthopaedic and blood purification products, has been seeking opportunities to bolster its product portfolio, the company said in a filing to the Hong Kong Stock Exchange. The company has also been looking to diversify its revenue stream to increase the contribution of sales from overseas markets, and expects "significant growth opportunities" for Argon Medical's products in China.